Altimmune, Inc. ALT
NASDAQ · United States · Health Technology
$2.74-0.02 (-0.91%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.12 | -0.14 | +13.4% | $0 | — | -4.0%$3.00→$2.88 |
| Q1 2026 | 2026-05-13 | -0.18 | -0.25 | +28.0% | — | — | -5.2%$3.08→$2.92 |
| Q4 2025 | 2026-03-05 | -0.27 | -0.24 | -12.5% | — | — | -17.1%$4.27→$3.54 |
| Q3 2025 | 2025-11-06 | -0.21 | -0.27 | +22.2% | — | — | +9.6%$3.75→$4.11 |
| Q2 2025 | 2025-08-12 | -0.27 | -0.32 | +15.6% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.26 | -0.34 | +23.5% | — | — | — |
| Q4 2024 | 2025-02-27 | -0.33 | -0.34 | +2.9% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.32 | -0.36 | +11.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.